Literature DB >> 27130984

Lobulated margination of liver hemangiomas: Is this a definitive feature?

António P Matos1, Yong Hwan Jeon2, Miguel Ramalho3, Mamdoh AlObaidy4, Richard C Semelka5.   

Abstract

PURPOSE: To evaluate the occurrence rate of lobulated margination of hepatic hemangiomas.
METHODS: The study population included 585 hemangiomas in 261 patients (161 females; mean age: 51.9years). Two readers independently reviewed all cases.
RESULTS: Hemangiomas with lobulated margins accounted for 74.7% of all lesions. The incidence of lobulated margins was significantly higher (P<.001) in medium- and large-sized hemangiomas (77.6% and 99.5%, respectively). The majority of hemangiomas with type-3 enhancement showed lobulated margins (83.5%) (P<.001).
CONCLUSION: Virtually, all hemangiomas>18mm show lobulated margins. The majority of hemangiomas with type-3 enhancement show lobulated margins. Lack of lobulated margins in larger lesions lowers the likelihood ratio for being hemangiomas.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lobulated margination; MRI; contour; liver hemangioma; size

Mesh:

Substances:

Year:  2016        PMID: 27130984     DOI: 10.1016/j.clinimag.2016.03.005

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  2 in total

1.  MRI features of primary rare malignancies of the liver: A report from four university centres.

Authors:  Richard C Semelka; Nadesan Nimojan; Saman Chandana; Miguel Ramalho; Suzanne L Palmer; Danielle DeMulder; Carolina Parada Villavicencio; John Woosley; Bonnie L Garon; Reena C Jha; Frank H Miller; Ersan Altun
Journal:  Eur Radiol       Date:  2017-10-27       Impact factor: 5.315

2.  Heterogeneity analysis of triphasic CT scan perfusion parameters in differential diagnosis of hepatocellular carcinoma and hemangioma.

Authors:  Guodong Pang; Zuyun Duan; Chunchun Shao; Fang Zhao; Hai Zhong; Guangrui Shao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.